SAMMVAX PTY LTD is an Australian Private Company registered in Queensland. The ABN was registered on the 1 October 2026 and is currently registered for GST and has been since the 1 October 2026. It was registered with ASIC on the 28 August 2026 as an Australian proprietary company, Limited by Shares.
Sammvax Pty Ltd is an Australian biotechnology company specialising in the development of infectious disease vaccines. Its primary focus is the advancement of TriVax, a trivalent vaccine intended to provide broad protection against Group A Streptococcus. The company's research aims to prevent severe medical complications linked to the bacterium, including rheumatic fever, sepsis, and rheumatic heart disease.
We weren't able to find any other public information on this company.
| Entity ID | Name | Status |
|---|
WGEA workforce data loads when this section is in view.